Skip to content

Study to assess impact of metabolic surgery on kidney disease in diabetic overweight patients

Prospective cohort study to evaluate impact of bariatric metabolic surgery(BMS)on nephropathy in 27.5-32.5 kgs/sqm body mass index type 2 diabetes patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/054983
Enrollment
50
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

None listed

Sponsors

Wockhardt Hospitals Limited, Mumbai Central
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult individuals 18-70 years of age 2. BMI: 27.5-32.5 kg/m2 (Class 1 obesity) 3. Known Type 2 Diabetes Mellitus > 1 year 4. Baseline HbA1c >7% on regular medical management

Exclusion criteria

Exclusion criteria: 1. Type 1 Diabetes Mellitus 2. Latent Auto-immune Diabetes of Adults (LADA) 3. Maturity Onset Diabetes of Young (MODY) 4. Previously operated bariatric and metabolic surgery patients 5. Patients with history of pancreatic disease or surgery 6. Patient at very high risk of anesthetic complications 7. Known endocrinal causes of obesity like Cushingâ??s syndrome 8. Patients who lack comprehension of the bariatric surgical procedures 9. Patients with known and uncontrolled psychiatric disorders like schizophrenia and major depression 10. Patients with active substance/ drug abuse 11. Patients unwilling to give the time commitment and consent

Design outcomes

Primary

MeasureTime frame
1Renal outcome measurements 2 HbA1c with or without antidiabetic medicationTimepoint: At 6 months & 1 year after surgery & annually after that for 2 more years

Secondary

MeasureTime frame
1. Other Micro-vascular complications(neuropathy & retinopathy) progression 2. Macro-vascular outcome(Carotid intimal thickness) measurements Timepoint: At 6 months & 1 year after surgery & annually after that for 2 more years

Countries

India

Contacts

Public Contactkhan sana

Wockhardt Hospital, Mumbai Central

ramengoel@gmail.com9820170763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026